🇳🇱 Netherlands Country × Condition
epithelial ovarian cancer Clinical Trials in Netherlands
Active clinical trials for epithelial ovarian cancer with research sites in Netherlands. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇳🇱 Netherlands
Active Trials in Netherlands (2)
NCT03862677
Recruiting
Determining Prognostic Immune Markers in Patients With Ovarian Cancer
Enrollment
300 pts
Country
🇳🇱 Netherlands
Leiden University Medical Center
View Trial → NCT05773859 Phase 1, Phase 2
Recruiting
NEOadjuvant Dendritic Cell Vaccination for Ovarian Cancer
Enrollment
10 pts
Country
🇳🇱 Netherlands
Radboud University Medical Center
View Trial → Frequently Asked Questions
How many epithelial ovarian cancer clinical trials are active in Netherlands?
There are currently 2 active clinical trials for epithelial ovarian cancer with sites in Netherlands, of which 2 are actively recruiting patients.
How can I join a epithelial ovarian cancer clinical trial in Netherlands?
To join a epithelial ovarian cancer clinical trial in Netherlands, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Netherlands directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are epithelial ovarian cancer trials in Netherlands?
Active epithelial ovarian cancer trials in Netherlands span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology